X-Linked Retinoschisis clinical trials at UCSF

1 research study open to eligible people

ATSN-201 Gene Therapy in RS1-Associated X-linked Retinoschisis
open to eligible people ages 6 years and up
This study will evaluate the safety and efficacy of ATSN-201 in subjects ≥ 6 years of age with RS1-associated X-linked retinoschisis (XLRS).
San Francisco, California and other locations

Last updated: September 3, 2026